NOT FOR DISTRIBUTION TO UNITED STATES TORONTO and CHICAGO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- . (“Medexus” or the “Company”) (TSX: MDP), is pleased to announce that it has launched an overnight ...

A D.C. drugmaker is fighting the FDA on multiple fronts, from trying protect its intellectual property from generic ...

A new cancer vaccine that ‘stops disease before you get it’ is being created by pharmaceutical giant GSK and the University ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Listless and lackadaisical for long stretches Thursday, Memphis basketball turned it on in time to come away with a 61-53 win ...

Jefferies has recently raised Crinetics Pharmaceuticals Inc (CRNX) stock to Buy rating, as announced on January 22, 2025, according to Finviz. Earlier, on March 6, 2024, Citigroup had initiated the ...

India's Mankind Pharma reported a smaller-than-expected third-quarter profit on Thursday, hurt by a sharp rise in expenses.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 11.63% ...

President Donald Trump is pulling the U.S. out of the World Health Organization, raising concerns about the U.N. agency's ...

For Zentalis Pharmaceuticals, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of ...